| Dr Robert Willard Clemons Jr, MD | |
|
220 Essie Davison Dr, Clarinda, IA 51632-2915 | |
| (712) 542-2176 | |
| (712) 542-8397 |
| Full Name | Dr Robert Willard Clemons Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 220 Essie Davison Dr, Clarinda, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013963339 | NPI | - | NPPES |
| 417824 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 23534 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montgomery County Memorial Hospital | Red oak, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montgomery County Memorial Hospital | 9032015805 | 35 |
News Archive
Kids who have just started smoking, but not on a daily basis, don't seem to recognize the early symptoms of dependence, according to a new study.
A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions.
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
› Verified 3 days ago
| Entity Name | Clarinda Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629196241 PECOS PAC ID: 4587573993 Enrollment ID: O20031205000207 |
News Archive
Kids who have just started smoking, but not on a daily basis, don't seem to recognize the early symptoms of dependence, according to a new study.
A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions.
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
› Verified 3 days ago
| Entity Name | Montgomery County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265405310 PECOS PAC ID: 9032015805 Enrollment ID: O20031211000423 |
News Archive
Kids who have just started smoking, but not on a daily basis, don't seem to recognize the early symptoms of dependence, according to a new study.
A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions.
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
› Verified 3 days ago
| Entity Name | Montgomery County Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1376539338 PECOS PAC ID: 9032015805 Enrollment ID: O20061104000347 |
News Archive
Kids who have just started smoking, but not on a daily basis, don't seem to recognize the early symptoms of dependence, according to a new study.
A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions.
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Willard Clemons Jr, MD Po Box 217, Clarinda, IA 51632-0217 Ph: (712) 542-2176 | Dr Robert Willard Clemons Jr, MD 220 Essie Davison Dr, Clarinda, IA 51632-2915 Ph: (712) 542-2176 |
News Archive
Kids who have just started smoking, but not on a daily basis, don't seem to recognize the early symptoms of dependence, according to a new study.
A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions.
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
› Verified 3 days ago
Dr. George William Richardson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-8330 Fax: 712-542-3373 | |
Dr. Bryon Jon Schaeffer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-8330 Fax: 712-542-8397 | |
Dr. Gerard J Stanley Sr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-8330 Fax: 712-542-3373 | |
Mitalee R. Dharwadkar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 Fax: 712-542-8397 | |
Ms. Kassandra Alysabeth Mellott, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 Fax: 712-542-8311 | |
Tonia M Baldwin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2000 N 16th St, Clarinda, IA 51632 Phone: 712-542-5634 Fax: 712-542-6112 |